Effects OF NMES With and Without Dynamic Bracing on Spasticity and Movement Quality in CP

April 7, 2025 updated by: Riphah International University

Effects of Neuromuscular Electrical Stimulation With and Without Dynamic Bracing on Lower Extremity Spasticity and Quality of Movement in Children With Cerebral Palsy

The study aims at comparing Neuromuscular electrical Stimulation with and without dynamic bracing on spasticity and movement quality of lower limb in Children with Cerebral Palsy

Study Overview

Detailed Description

Cerebral palsy (CP) is a lifelong motor impairment caused by an early brain injury and affects 2-3 per 1,000 live births. It is a complex medical condition that negatively impacts cognition, language, sensations, movement, and gait patterns. It is normally carried out using a comprehensive approach that incorporates numerous approaches targeted at minimizing symptoms and improving functional outcomes.

NMES (Neuromuscular and Muscular Electrical Stimulation) is an instrument that provides electrical impulses to nerves, causing muscles to contract, while dynamic bracing use muscle power to pre-compress soft tissue to produce the high forces required to control specific pathological diseases.

The hip adductors, the knee flexor muscles, and the ankle and foot muscles (gastrocnemius and soleus may experience increased tone, causing the ankles to be held in a plantar-flexed (pointed downward) position) are targeted with NMES in the lower extremity to reduce the spasticity & improve the quality of movement in CP children. Investigating how combining NMES with dynamic bracing benefits lumbar disc bulge patients adds to the growing body of evidence supporting multimodal treatment.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Faisalābad, Punjab, Pakistan, 54000
        • Children Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age between 5 to 12 years.
  • Able to walk with or without an assistive device. Classification as level I-II on the Gross Motor Functional Classification System (GMFCS).
  • Able to stand with or without support for 1 minute.
  • Classification as levels I-III on the Manual Ability Classification System (MACS); and the ability to follow and accept verbal instructions.
  • Muscle tone scored ≥2, according to Modified Ashworth Scale.

Exclusion Criteria:

  • Orthopedic Surgical intervention (e.g. tendon lengthening in lower limb) within the previous 12 months
  • Treatment with botulinum toxin in the calf muscles within the previous 6 months
  • Presence of structural deformities at the lower limbs and trunk, or instability in the ankle joint, which could compromise the child's safety and performance of the motor task
  • Severe affective or psychiatric impairments;
  • Serious vision or hearing problems
  • Any neurological impairment (epilepsy or any other disease that would interfere with physical activity)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: NMES with Dynamic Bracing
The NMES targeting the hip adductors, the knee flexor muscles and the ankle & foot muscles, along with dynamic bracing
The group will receive NMES along with dynamic bracing
Experimental: NMES without Dynamic Bracing
Neuromuscular Electrical Stimulator targeting the lower extremity
The participants will receive NMES on the lower extremity
Experimental: Dynamic Bracing Only
Dynamic Bracing of lower extremity
This group will receive dynamic bracing only on the lower limb.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Ashworth Scale
Time Frame: baseline and 6 weeks
The scale is used to measure spasticity minimum score is 0 and maximum score is 4
baseline and 6 weeks
Observable Movement Quality Scale
Time Frame: baseline and 6 weeks
it is used assess the movement quality in children Minimum Score: 0 (indicating the poorest movement quality) and maximum is 24
baseline and 6 weeks
Physicians Rating Scale
Time Frame: baseline and 6 weeks
it is used to objectively documenting the hip, knee, ankle and foot changes in children with CP. Minimum Score: 0 (indicating no impairment or lowest severity) and Maximum score is 7
baseline and 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ammara Abbas, tDPT, Riphah International University
  • Principal Investigator: Ayesha Ashraf, MS NMPT*, Ripha International Univerisity

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 30, 2023

Primary Completion (Actual)

May 14, 2024

Study Completion (Actual)

May 14, 2024

Study Registration Dates

First Submitted

March 4, 2024

First Submitted That Met QC Criteria

March 4, 2024

First Posted (Actual)

March 12, 2024

Study Record Updates

Last Update Posted (Actual)

April 9, 2025

Last Update Submitted That Met QC Criteria

April 7, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diplegic Spastic Cerebral Palsy

Clinical Trials on NMES with Dynamic Bracing

Subscribe